Melanoma Experimental Drug Shows Promise In Late Stage Skin Cancer

In what appears to show great promise, researchers are hopeful that they might have a drug against the deadlines form of skin cancer.

“An experimental drug significantly improved survival in a major study of people with very advanced disease,” AP has reported.

“We have not had any therapy that has prolonged survival” until now, Dr. Lynn Schuchter of the Abramson Cancer Center at the University of Pennsylvania, a skin cancer specialist with no role in the study or ties to the drug’s maker, said the AP reported.

“The drug, ipilimumab, (ip-ee-LIM-uh-mab), works by helping the immune system fight tumors. The federal Food and Drug Administration has pledged a quick review, and doctors think the drug could be available by the end of this year.

“People are going to have a lot of hope and want this drug, and it’s not on their doctors’ shelves,” although some may be able to get it through special programs directly from its maker, Bristol-Myers Squibb Co., Schuchter said.

For the rest of the story.

Similar Posts: